Global 3D Bioprinting Market to Reach US$ 4,281.9 Million by 2032, Bolstered by Technological Advancements

December 20, 2021 | Healthcare

The latest report by IMARC Group, titled “3D Bioprinting Market Report by Component (3D Bioprinters, Scaffolds, Biomaterials), Application (Research, Clinical), End User (Hospitals, Research Organization and Academic Institutes, Biopharmaceuticals Companies), and Region 2024-2032,” finds that the global 3D bioprinting market reached a value of US$ 1,205.8 Million in 2023. 3D bioprinting refers to the medical application of 3D printers for fabricating biological tissues and organs through the layering of living cells. It creates spatially-controlled patterns in 3D where viability and cell function are conserved within the printed construct. 3D bioprinting utilizes a layer-by-layer method to deposit materials like bio-inks. Bio-inks are obtained from living cells, biomaterials, and active biomolecules to create the 3D structure of tissues and organs. The technology offers speedy and accurate drug testing as potential drug compounds can be tested on bio-printed tissue before being used in human trials. It is also used to build complex bodily structures, including bones, skin, vascular grafts, tracheal splints, heart tissues, and cartilages. As a result, 3D bioprinting finds applications in the research and development of drugs, scaffolds, and medical implants.

Global 3D Bioprinting Market Trends: 

The market is primarily driven by the increasing geriatric population and rising instances of respiratory and cardiovascular diseases that require organ transplants. The limited number of organ donors is propelling the demand for 3D bioprinting across healthcare organizations. In addition to this, the technology is used in cosmetic surgeries and the pharmaceutical industry, further supplementing the market growth. This has also resulted in growing public and private fundings, which have prompted market players to improve and strengthen their manufacturing and distribution capabilities. As a result, 3D bioprinting is used to create simple tissue structures in a lab setting; however, it can also build complete organs for transplants in the future, owing to technological advancements and the manufacturing of customized products. Moreover, manufacturers have introduced organ-on-a-chip and bio-printed structures that enable a 3D in-vitro analysis of bodily functions and aids in developing artificial organs and tissues. Furthermore, extensive R&D investments and increasing stem cell research have increased awareness regarding 3D bioprinting, which is positively influencing the market growth. Looking forward, the market value is expected to reach US$ 4,281.9 Million by 2032, exhibiting a CAGR of 14.7% during the forecast period (2024-2032).

Market Summary: 

  • Based on the component, the market has been segmented into 3D bioprinters (syringe/extrusion, inkjet, magnetic levitation, laser-assisted and other bioprinting), scaffolds, and biomaterials (living cells, hydrogels, extracellular matrices and others).
  • On the basis of the application, the market has been classified into research (drug research, regenerative medicine and 3D cell culture) and clinical (skin, bone and cartilage, blood vessels and others).
  • The market has been categorized based on the end user into hospitals, research organization and academic institutes and biopharmaceuticals companies.
  • Region-wise, the market has been divided into North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia and others), Latin America (Brazil, Mexico and others) and Middle East and Africa.
  • The competitive landscape of the market has been examined, with some of the key players being 3D Systems Inc., Aspect Biosystems Limited, Cellink AB, Cyfuse Biomedical K.K., EnvisionTEC GmbH (Desktop Metal Inc.), GeSiM – Gesellschaft für Silizium-Mikrosysteme mbH, Materialise NV, Organovo Holdings Inc., Poietis, regenHU Limited and Stratasys Limited.

Report Scope:

Report Features Details
Base Year of the Analysis 2023
Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Million
Segment Coverage Component, Application, End User, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered 3D Systems Inc., Aspect Biosystems Ltd., Cellink, Cyfuse Biomedical K.K., EnvisionTEC GmbH (Desktop Metal Inc.), GeSiM – Gesellschaft für Silizium-Mikrosysteme mbH, Materialise, Organovo Holdings Inc., Poietis, RegenHU and Stratasys Ltd.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 3899
Five User License: US$ 4899
Corporate License: US$ 5899
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:


USA: +1-631-791-1145
Follow us on twitter : @imarcglobal

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global 3D Bioprinting Market to Reach US$ 4,281.9 Million by 2032, Bolstered by Technological Advancements
Purchase options

Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us

Phone: +1-631-791-1145


Phone: +91-120-433-0800


Phone: +44-753-713-2163


Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More